- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.10. | Shionogi's Xocova effective in preventing symptomatic COVID-19: study | 3 | Seeking Alpha | ||
| 29.10. | Shionogi & Co. reports Q2 results | 4 | Seeking Alpha | ||
| 01.10. | Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ in Japan | 174 | GlobeNewswire (Europe) | QUVIVIQ is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as insomnia Tokyo, Japan and Cambridge, UK, 1 October 2024... ► Artikel lesen | |
| 30.07. | Earnings call: Shionogi reports mixed results, optimistic on pipeline progress | 10 | Investing.com | ||
| 09.05. | Global Health Innovative Technology Fund (GHIT Fund): Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions | 1.071 | PR Newswire | TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects... ► Artikel lesen | |
| SHIONOGI & CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| 22.12.23 | Juniper Biologics: Juniper Therapeutics Acquires Exclusive Rights for SAR Registration for Anti-Viral COVID-19 Drug from Ping An-Shionogi Hong Kong for Singapore | 760 | PR Newswire | First drug to show both clinical symptomatic efficacy for five typical Omicron-related symptoms and antiviral efficacy
SINGAPORE, Dec. 21, 2023 /PRNewswire/ -- Singapore-headquartered... ► Artikel lesen | |
| 20.12.23 | Pixie Dust Technologies, Inc.: "Bekämpfen von Demenz mit Klangtherapie"- Pixie Dust Technologies, Shionogi und Shionogi Healthcare entwickeln Gamma-Wellen-Klänge zur Verbesserung der alltäglichen kognitiven Fähigkeiten | 746 | Business Wire | Pixie Dust Technologies, Inc., Shionogi Co. und Shionogi Healthcare Co. haben mit "Memory" und "Tomorrow" zwei Hörerlebnisse auf Basis der Gamma-Wellen-Technologie1 veröffentlicht, die Demenzpatienten... ► Artikel lesen | |
| 20.12.23 | Pixie Dust Technologies, Inc.: "Defy Dementia with Sound." Pixie Dust Technologies, Shionogi and Shionogi Healthcare create Gamma Wave Sound to boost everyday cognitive care. | 889 | Business Wire | Pixie Dust Technologies, Inc., Shionogi Co., Ltd, and Shionogi Healthcare Co., Ltd released "Memory" and "Tomorrow", two audio experiences incorporating gamma wave technology1 designed to provide... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TRULIEVE CANNABIS | 5,890 | +0,60 % | Trulieve Cannabis Corp: Trulieve opens two new dispensaries in Florida | ||
| WEST PHARMACEUTICAL SERVICES | 302,40 | -1,27 % | Kursgewinne für die Aktie von West Pharmaceutical Services (292,3337 €) | An der US-amerikanischen Börse liegt die Aktie von West Pharmaceutical Services zur Stunde im Plus. Das Papier kostete zuletzt 308,07 US-Dollar. Heute hat sich am US-amerikanischen Aktienmarkt das Wertpapier... ► Artikel lesen | |
| SHIONOGI | 12,500 | -2,34 % | Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ in Japan | QUVIVIQ is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as insomnia Tokyo, Japan and Cambridge, UK, 1 October 2024... ► Artikel lesen | |
| HERITAGE CANNABIS | 0,001 | 0,00 % | Heritage Cannabis Holdings Corp.: Heritage Cannabis Announces Completion of Sale and Delisting from the CSE and the OTCQX | TORONTO, Aug. 29, 2024 /CNW/ - Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) ("Heritage" or the "Company") today announces, that, in connection with its creditor protection proceedings... ► Artikel lesen | |
| KALA BIO | 6,040 | -4,35 % | KALA BIO, Inc. - 10-Q, Quarterly Report | ||
| CHARLOTTES WEB | 0,121 | -0,82 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports 2024 Third quarter Financial Results | Sequential quarterly growth returns for 2024 New Product Innovations Driving Omni-Channel Expansion
LOUISVILLE, Colo., Nov. 14, 2024 /PRNewswire/ - (TSX: CWEB... ► Artikel lesen | |
| BEXIMCO | 0,360 | -1,10 % | Government intervenes with emergency loan package to resolve Beximco labour unrest | ||
| LUYE PHARMA | 0,312 | +0,65 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR CLASS 1 INNOVATIVE ANTIDEPRESSANT LY03021 FOR CLINICAL TRIALS IN CHINA | ||
| MIRUM PHARMACEUTICALS | 42,200 | +1,44 % | Mirum Pharmaceuticals (NASDAQ:MIRM) Trading Down 4.6% After Insider Selling | ||
| GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc. - 8-K, Current Report | ||
| PERCHERON THERAPEUTICS | 0,048 | +2,13 % | PERCHERON THERAPEUTICS LIMITED: Proposed issue of securities - PER | ||
| AYURCANN | 0,017 | +3,03 % | Ayurcann Holdings Corp.: Ayurcann Terminates Business Combination | Toronto, Ontario, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company"), a leading Canadian processing and manufacturing company specializing... ► Artikel lesen | |
| AVANT BRANDS | 0,388 | 0,00 % | Avant Brands Inc.: Avant Brands Announces Results for Q3 2024 | Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records.Record Export Wholesale Revenue1: Generated $5.1 million... ► Artikel lesen | |
| KALBE FARMA | 0,079 | -0,63 % | KLBF strengthens prescription drug business by inaugurating radioisotope factory: PT Kalbe Farma Tbk ... | ||
| EVEREST MEDICINES | 4,520 | -1,74 % | Everest Medicines Limited: Everest Medicines Announces NEFECON(R)'s Full Approval in South Korea | - Marking Another Milestone in CommercializationHONG KONG, Nov 19, 2024 - (ACN Newswire) - Today, Everest Medicines announced that NEFECON(R) has received full approval from the Ministry of Food and... ► Artikel lesen |
SHIONOGI & CO LTD ADR gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 6,700 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHIONOGI & CO LTD ADR finden Sie auf Wallstreet Online.
